Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: https://bit.ly/2MSNOQz | Journal of the American Academy of Dermatology (JAAD)

7.5K views · 64 reactions | Some patients with chronic obstructive pulmonary disease have evidence of type 2 inflammation, including elevated blood eosinophil counts. Research findings on subcutaneous dupilumab in these patients are summarized in a new Quick Take video. https://nej.md/4dF7N06 | The New England Journal of Medicine | Facebook